Patents-Review.com
ClassID:

110857 ⎘

C12N2760/16334 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus C, i.e. influenza C virus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20250011731
2025-01-09

PRODUCTION OF VIRUSES IN CELL CULTURE

 #2
20240269258
2024-08-15

MULTIVALENT INFLUENZA VACCINES

 #3
20230416311
2023-12-28

Influenza vaccines

 #4
20220106574
2022-04-07

Production of viruses in cell culture

 #5
20220025029
2022-01-27

Human antibodies to Fel d1 and methods of use thereof

 #6
20220002352
2022-01-06

Influenza vaccines

 #7
20190322989
2019-10-24

Production of viruses in cell culture

 #8
20190203186
2019-07-04

Production of viruses in avian eggs

 #9
20190078056
2019-03-14

METHOD FOR CULTURING MDCK CELLS

 #10
20190008949
2019-01-10

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA

 #11
20180340154
2018-11-29

Production of viruses in avian eggs

 #12
20180340153
2018-11-29

Production of viruses in cell culture

 #13
20180305446
2018-10-25

Human antibodies to Fel d1 and methods of use thereof

 #14
20180230187
2018-08-16

Influenza vaccines

 #15
20170210790
2017-07-27

Human antibodies to Fel d1 and methods of use thereof

 #16
20160376358
2016-12-29

Human antibodies to fel D1 and methods of use thereof

 #17
20160235831
2016-08-18

Process for stabilizing an adjuvant containing vaccine composition

 #18
20160220483
2016-08-04

Thermally stable vaccine formulations and microneedles

 #19
20150299303
2015-10-22

Human antibodies to fel d1 and methods of use thereof

 #20
20150190499
2015-07-09

BOVINE INFLUENZA C VIRUS COMPOSITIONS

 #21
20130295097
2013-11-07

Human antibodies to Fel d1 and methods of use thereof

 #22
20130195915
2013-08-01

Influenza C virus and vaccine

 #23
20130183342
2013-07-18

Computationally optimized broadly reactive antigens for influenza

 #24
20120148622
2012-06-14

Live attenuated influenza virus vaccines comprising microRNA response elements

 #25
20110117128
2011-05-19

Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof

 #26
20100196411
2010-08-05

Yeast-Based Vaccine for Inducing an Immune Response

 #27
20090232894
2009-09-17

Process for stabilizing an adjuvant containing vaccine composition

 #28
20080254067
2008-10-16

Process for the Production of an Influenza Vaccine

 #29
20080003239
2008-01-03

Yeast-based vaccine for inducing an immune response

 #30
20070253982
2007-11-01

Compositions that include hemagglutinin

 #31
20070224205
2007-09-27

Compositions that include hemagglutinin, methods of making and methods of use thereof

 #32
18670803
2024-10-08

Stabilized hemagglutinin (HA) trimers as influenza vaccine antigens